adamantane has been researched along with HIV Coinfection in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Abdullah, ES; Alanazi, AM; Almutairi, MS; El-Emam, AA; Pathak, SK; Prasad, O; Sinha, L; Srivastava, R | 1 |
de Béthune, MP; De Meyer, S; Dierynck, I; Lathouwers, E; Picchio, G; Spinosa-Guzman, S; Van De Casteele, T; Vanden Abeele, C | 1 |
Binnington, B; Blumenthal, R; Branch, DR; Chark, D; Fantini, J; Lingwood, CA; Lund, N; Ma, XZ; Mylvaganam, M; Puri, A; Sakac, D | 1 |
Deray, G; Issad, B; Izzedine, H; Launay-Vacher, V | 1 |
1 review(s) available for adamantane and HIV Coinfection
Article | Year |
---|---|
Anti-viral drugs in continuous ambulatory peritoneal dialysis (CAPD).
Topics: Adamantane; Anti-HIV Agents; Antimetabolites; Antiviral Agents; Dideoxynucleosides; Foscarnet; Hepatitis, Viral, Human; Herpesviridae Infections; HIV Infections; HIV Protease Inhibitors; Humans; Interferon-alpha; Kidney; Kidney Failure, Chronic; Peritoneal Dialysis, Continuous Ambulatory; Protein Binding; Reverse Transcriptase Inhibitors; Virus Diseases | 2002 |
1 trial(s) available for adamantane and HIV Coinfection
Article | Year |
---|---|
In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients.
Topics: Adamantane; Adult; Analysis of Variance; Atazanavir Sulfate; Carbamates; Darunavir; Drug Resistance, Viral; Furans; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Indinavir; Lopinavir; Microbial Sensitivity Tests; Molecular Typing; Nelfinavir; Neuraminidase; Oligopeptides; Pyridines; Pyrimidinones; Pyrones; Saquinavir; Sulfonamides; Viral Load | 2010 |
2 other study(ies) available for adamantane and HIV Coinfection
Article | Year |
---|---|
FT-IR and FT-Raman spectroscopic signatures, vibrational assignments, NBO, NLO analysis and molecular docking study of 2-{[5-(adamantan-1-yl)-4-methyl-4H-1,2,4-triazol-3-yl]sulfanyl}-N,N-dimethylethanamine.
Topics: Adamantane; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Molecular Docking Simulation; Quantum Theory; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Triazoles | 2015 |
A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection.
Topics: Adamantane; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glycolipids; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Jurkat Cells; Leukocytes, Mononuclear; Microscopy, Electron; Trihexosylceramides | 2006 |